thymosin beta-4 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-09-05. Numbers and descriptions here follow the published literature rather than marketing material.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 4963 Da for full-length thymosin beta-4 | Value applies to the parent protein; fragment products may differ |
| Appearance | White to off-white lyophilized powder | Typical form of supplied synthetic peptide |
| Solubility | Freely soluble in water | Polar peptide; dissolves readily in aqueous buffer |
| Storage of dry powder | −20 °C, desiccated, protected from light | Standard laboratory practice for peptides |
| Typical detection method | Liquid chromatography–tandem mass spectrometry | Used in purity testing and anti-doping analysis |
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
Once dissolved, the peptide is far less stable than the dry powder. Aqueous solutions are subject to hydrolysis, oxidation at susceptible residues and gradual loss of material through adsorption onto glass and plastic surfaces. Terminal glutamine can cyclise under some conditions, producing a related species that complicates purity assessment. Dilute solutions tend to lose a larger fraction of material to surfaces than concentrated ones. Buffers, pH and ionic strength all influence the rate of change, so stability figures are only meaningful when those parameters are stated alongside the storage interval.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
=== Pregnancy === Dexamethasone may be given to women at risk of delivering prematurely to promote maturation of the fetus's lungs. This administration, given from one day to one week before delivery, has been associated with low birth weight, although not with increased rates of neonatal death. Dexamethasone has also been used during pregnancy as an off-label prenatal treatment for the symptoms of congenital adrenal hyperplasia (CAH) in female babies. CAH causes a variety of physical abnormalities, notably ambiguous genitalia. Early prenatal CAH treatment has been shown to reduce some CAH symptoms, but it does not treat the underlying congenital disorder. This use is controversial: it is inadequately studied, only around one in ten of the fetuses of women treated are at risk of the condition, and serious adverse events have been documented. Experimental use of dexamethasone in pregnancy for fetal CAH treatment was discontinued in Sweden when one in five cases had adverse events. A small clinical trial found long-term effects on verbal working memory among the small group of children treated prenatally, but the small number of test subjects means the study cannot be considered definitive.
Increases levels of dehydroepiandrosterone (DHEA) directly by action on the fetal adrenal gland, and indirectly via the mother's pituitary gland. DHEA has a role in preparing for and stimulating cervical contractions. Increases prostaglandin availability in uteroplacental tissues. Prostaglandins activate cervical contractions. Prior to parturition it may have a role inhibiting contractions, through increasing cAMP levels in the myometrium. In culture, trophoblast CRH is inhibited by progesterone, which remains high throughout pregnancy. Its release is stimulated by glucocorticoids and catecholamines, which increase prior to parturition lifting this progesterone block.
In 1900, the German colonial administration of Nauru granted phosphate rights to British businessman John T. Arundel's Pacific Islands Company (PIC). The PIC was replaced by the Pacific Phosphate Company (PPC) in 1902, with German interests holding around one-third of the company's share capital. Production commenced in 1906, largely relying on indentured labour, with Australia and New Zealand as the primary markets. In 1914, following the outbreak of the First World War, the Australian Naval and Military Expeditionary Force occupied Nauru, with an agreement reached whereby the Australian military would assume administrative control of the island and the PPC would continue phosphate operations. Following the end of the war, Nauru was made a League of Nations mandate under the joint trusteeship of Australia, New Zealand and the United Kingdom, with Australia retaining administration of the island. In 1919, the three trustees signed the Nauru Island Agreement, which entitled them to the phosphate of Nauru through the British Phosphate Commissioners. They bought back all the assets of the PPC for more than 3.5 million pounds on 1 July 1920, and started to manage it directly on 1 January 1921, after a six-month transition period of PPC management. Most of PPC's former employees were retained by the BPC.
Sources: en.wikipedia.org
At Mulhouse, Wenger was managed by Paul Frantz, who also had a profound impact on his career. It was he who formalised Wenger's beliefs on the importance of nutrition, isometrics and working on a player's strong points. Wenger played in midfield for Mulhouse, often positioned on the right. In their final game of the 1974–75 season, the club beat Nancy to avoid relegation, but shortly afterwards, Frantz resigned. Wenger also made the decision to leave, as the regular commutes to Mulhouse from Strasbourg overwhelmed him. In 1975, he rekindled his friendship with Hild and signed for amateur club ASPV Strasbourg (Vauban). Hild needed a midfielder "who could organise play and also have a sort of hold over the team" and decided to recruit Wenger. Vauban was formed in 1971, and made steady progress up the French football league system thereafter; Wenger's three seasons at the club culminated with promotion to the third division.
In 1929, the country was renamed to Yugoslavia and the football association became Fudbalski savez Jugoslavije and ordered to move its headquarters from Zagreb to Belgrade. The national team participated at the 1930 FIFA World Cup, finishing in fourth place. In its first ever World Cup match in Montevideo's Parque Central, Yugoslavia managed a famous 2–1 win versus mighty Brazil, with the following starting eleven representing the country: Milovan Jakšić, Branislav Sekulić, Aleksandar Tirnanić, Milutin Ivković, Ivica Bek, Momčilo Đokić, Blagoje Marjanović, Milorad Arsenijević, Đorđe Vujadinović, Dragoslav Mihajlović, and Ljubiša Stefanović. The team was the youngest squad at the inaugural World Cup at an average age of just under 22 years old, and became quite popular among the Uruguayan public, who dubbed them "Los Ichachos". The national team consisted of players based in Serbian football clubs, while the Zagreb Subassociation forbid players from Croatian clubs, some of whom were regulars in the national team until then, to play in the World Cup due to the relocation of football association's headquarters from Zagreb to Belgrade.
==== 1.D Non-ribosomally synthesized channels ==== 1.D.1 The Gramicidin A Channel Family 1.D.2 The Channel-forming Syringomycin Family 1.D.3 The Channel-Forming Syringopeptin Family 1.D.4 The Tolaasin Channel-forming Family 1.D.5 The Alamethicin or Peptaibol Antibiotic Channel-forming Family 1.D.6 The Complexed Poly 3-Hydroxybutyrate Ca2+ Channel (cPHB-CC) Family 1.D.7 The Beticolin Family 1.D.8 The Saponin Family 1.D.9 The Polyglutamine Ion Channel (PG-IC) Family 1.D.10 The Ceramide-forming Channel Family 1.D.11 The Surfactin Family 1.D.12 The Beauvericin (Beauvericin) Family 1.D.13 DNA-delivery Amphipathic Peptide Antibiotics (DAPA) 1.D.14 The Synthetic Leu/Ser Amphipathic Channel-forming Peptide (l/S-SCP) Family 1.D.15 The Daptomycin (Daptomycin) Family 1.D.16 The Synthetic Amphipathic Pore-forming Heptapeptide (SAPH) Family 1.D.17 Combinatorially-designed, Pore-forming, β-sheet Peptide Family 1.D.18 The Pore-forming Guanosine-Bile Acid Conjugate Family 1.D.19 Ca2+ Channel-forming Drug, Digitoxin Family 1.D.20 The Pore-forming Polyene Macrolide Antibiotic/fungal Agent (PMAA) Family 1.D.21 The Lipid Nanopore (LipNP) Family 1.D.22 The Proton-Translocating Carotenoid Pigment, Zeaxanthin Family 1.D.23 Phenylene Ethynylene Pore-forming Antimicrobial (PEPA) Family 1.D.24 The Marine Sponge Polytheonamide B (pTB) Family 1.D.25 The Arylamine Foldamer (AAF) Family 1.D.26 The Dihydrodehydrodiconiferyl alcohol 9'-O-β-D-glucoside (DDDC9G) Family 1.D.27 The Thiourea isosteres Family 1.D.28 The Lipopeptaibol Family 1.D.29 The Macrocyclic Oligocholate Family 1.D.30 The Artificial Hydrazide-appended pillar[5]arene Channels (HAPA-C) Family 1.D.31 The Amphotericin B Family 1.D.32 The Pore-forming Novicidin Family 1.D.33 The Channel-forming Polytheonamide B Family 1.D.34 The Channel-forming Oligoester Bolaamphiphiles 1.D.35 The Pore-forming cyclic Lipodepsipeptide Family 1.D.36 The Oligobornene Ion Channel Family 1.D.37 The Hibicuslide C Family 1.D.38 The Cyclic Peptide Nanotube (cPepNT) Family 1.D.39 The Light-controlled Azobenzene-based Amphiphilic Molecular Ion Channel (AAM-IC) Family 1.D.40 The Protein-induced Lipid Toroidal Pore Family 1.D.41 The Sprotetonate-type Ionophore (Spirohexanolide) Family 1.D.42 The Phe-Arg Tripeptide-Pillar[5]Arene Channel (TPPA-C) Family 1.D.43 The Triazole-tailored Guanosine Dinucleoside Channel (TT-GDN-C) Family 1.D.44 The Synthetic Ion Channel with Redox-active Ferrocene (ICRF) Family 1.D.45 The Sonoporation and Electroporation Membrane Pore (SEMP) Family 1.D.46 The DNA Nanopore (DnaNP) Family 1.D.47 The Pore-forming Synthetic Cyclic Peptide (PSCP) Family 1.D.48 The Pore-forming Syringomycin E Family 1.D.49 The Transmembrane Carotenoid Radical Channel (CRC) Family 1.D.50 The Amphiphilic bis-Catechol Anion Transporter (AC-AT) Family 1.D.51 The Protein Nanopore (ProNP) Family 1.D.52 The Aromatic Oligoamide Macrocycle Nanopore (OmnNP) Family 1.D.53 The alpha, gamma-Peptide Nanotube (a,gPepNT) Family 1.D.54 The potassium-selective Hexyl-Benzoureido-15-Crown-5-Ether Ion Channel (HBEC) Family 1.D.55 The Porphyrin-based Nanopore (PorNP) Family 1.D.56 The Alpha-Aminoisobutyrate (Aib) Oligomeric Nanopore (AibNP) Family 1.D.57 The Lipid Electro-Pore (LEP) Family 1.D.58 The Anion Transporting Prodigiosene (Prodigiosene) Family 1.D.59 The Anion Transporting Perenosin (Perenosin) Family 1.D.60 The Alpha,Gamma-Cyclic Peptide (AGCP) Family 1.D.61 The Anionophoric 2,6-Bis(Benzimidazol-2-yl)Pyridine (ABBP) Family 1.D.62 The Bis-Triazolyl DiGuanosine Derivative Channel-forming (TDG) Family 1.D.63 The Peptide-based Nanopore (PepNP) Family 1.D.64 The Carbon Nanotube (CarNT) Family 1.D.65 The Pore-forming Amphidinol (Amphidinol) Family 1.D.66 The Helical Macromolecule Nanopore (HmmNP) Family 1.D.67 The Crown Ether-modified Helical Peptide Ion Channel (CEHP) Family 1.D.68 The Pore-forming Pleuronic Block Polymer (PPBP) Family 1.D.69 The Conical Nanopore (ConNP) Family 1.D.70 The Metallic (Au/Ag/Pt/graphene) Nanopore (MetNP) Family 1.D.71 The Synthetic TP359 Peptide (TP359) Family 1.D.72 The Chloride Carrier Triazine-based Tripodal Receptor (CCTTR) Family 1.D.73 The Mesoporous Silica Nanopore (SilNP) Family 1.D.74 The Stimulus-responsive Synthetic Rigid p-Octiphenyl Stave Pore (SSROP) Family
Sources: en.wikipedia.org
Beta-adrenergic receptors (β1, β2, β3) stimulate lipolysis through Gs-protein-coupled activation of adenylyl cyclase and subsequent cAMP production, while alpha-2 adrenergic receptors (α2A) inhibit lipolysis through Gi-protein-mediated suppression of adenylyl cyclase. Subcutaneous abdominal adipose tissue exhibits a higher α2:β ratio compared to visceral adipose tissue, which is predominantly β3-receptor-expressing and more lipolytically responsive to catecholamine stimulation.
Multipolar neurons: Have 3 or more processes coming off the soma (cell body). They are the major neuron type in the CNS and include interneurons and motor neurons. Bipolar neurons: Sensory neurons that have two processes coming off the soma, one dendrite and one axon Pseudounipolar neurons: Sensory neurons that have one process that splits into two branches, forming the axon and dendrite Unipolar brush cells: Are excitatory glutamatergic interneurons that have a single short dendrite terminating in a brush-like tuft of dendrioles. These are found in the granular layer of the cerebellum. Neuroglia encompasses the non-neural cells in nervous tissue that provide various crucial supportive functions for neurons. They are smaller than neurons, and vary in structure according to their function. Neuroglial cells are classified as follows:
=== Supporters === Pritzker has gained support from progressives and socialists for his stances on healthcare, education, raising the minimum wage, legalizing recreational marijuana, and expanding access to healthcare. His administration has been considered one of the most progressive in the United States.
Sources: en.wikipedia.org
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.
No. No major regulatory authority lists an approved product under this name, and no pharmacopoeial monograph exists for it. Material sold under the label is therefore supplied outside approved pharmaceutical channels, which affects the quality documentation available.
It falls within a prohibited class covering peptide hormones and growth factors, based on presumed effects on tissue repair and blood vessel formation. Anti-doping laboratories have published mass spectrometry methods for detecting thymosin beta-4 related peptides in urine samples.
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.